Skip to content
value.today

Helicos Biosciences Corp.

Total raised
$10 M
1 round on record
Latest round
$10 M
Sep 2009
First round on record
Sep 2009
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Helicos Biosciences Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2009$10 MNo. 1$10 to $50 million

Helicos Biosciences Corp.: Raise no. 1, Sep 2009

Investors in this round

25 investors had bought by the notice of Sep 29, 2009: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$487,750
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ronald A. Lowry · Executive Officer, Director
  • Stephen J. Lombardi · Executive Officer, Director
  • Brian G. Atwood · Director
  • Elisabeth K. Allison · Director
  • Noubar B. Afeyan · Director
  • Peter G. Barrett · Director
  • Robert F. Higgins · Director
  • Stanley N. Lapidus · Director
  • Theo F. Melas-Kyriazi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • THOMAS WEISEL PARTNERS LLC (CRD 46237) · San Francisco, CaSold in no state named

Remarks in the notice

  • On fees: “SALES COMMISSION AMOUNT INCLUDES $10,000 IN REIMBURSABLE EXPENSES.”

Signed by Jeffrey R. Moore, Senior vice presdient and chief financial officer. Source: SEC Form D, newest notice filed Sep 29, 2009. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Helicos Biosciences Corp. chose not to state its revenue in its newest notice of a funding round (Sep 2009).

    SEC Form D · Sep 2009

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Sep 2009

That is all the official record says: Helicos Biosciences Corp. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Helicos Biosciences Corp. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 25 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Helicos Biosciences Corp.
NameRoleNamed in
Ronald A. LowryExecutive officerSep 2009
Stephen J. LombardiExecutive officerSep 2009
Brian G. AtwoodDirectorSep 2009
Elisabeth K. AllisonDirectorSep 2009
Noubar B. AfeyanDirectorSep 2009
Peter G. BarrettDirectorSep 2009
Robert F. HigginsDirectorSep 2009
Ronald A. LowryDirectorSep 2009
Stanley N. LapidusDirectorSep 2009
Stephen J. LombardiDirectorSep 2009
Theo F. Melas-KyriaziDirectorSep 2009